The agreement grants Aurigene access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio. Through this license, Aurigene can integrate precision genome editing capabilities into its discovery ...
The U.S. Patent and Trademark Office issued Caribou Biosciences, a startup co-founded by UC Berkeley researcher Jennifer Doudna, intellectual property rights for developments in CRISPR gene-editing ...
Dr Giovanni Pietrogrande and Dr Tahmina Tabassum developed their new fusion protein at UQ's Australian Institute for Bioengineering and ...
The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5, a protein found on ...
Structural alterations of the genome are commonly observed in human cancer and can contribute to tumorigenesis through a variety of mechanisms including the formation of fusion oncoprotein and changes ...
Announcing a new article publication for Zoonoses journal. As global warming increases, mosquito activity areas are expanding, alongside changes in the natural environment and the misuse of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results